Genvax Technologies


Genvax Technologies is an Ames, Iowa–based startup developing next-generation mRNA plus nanoparticle vaccines for livestock. The company emphasizes rapid variant updating, custom herd-specific vaccine design with traceable data, and scalable manufacturing to reduce cost and speed deployment. Leadership includes experienced founders and staff in R&D and regulatory roles.

Industries

Biotechnology
Biotechnology Research

Nr. of Employees

small (1-50)

Genvax Technologies


Services

Collaborative development of mRNA plus nanoparticle vaccines tailored to specific herds or production systems for prevention and treatment of animal diseases.

Partnership engagement services for producers, veterinarians, and industry organizations to pilot, evaluate, and deploy vaccine programs.

Communications and due-diligence support for investors and strategic funders.

Expertise Areas

  • Veterinary vaccine development
  • mRNA vaccine platforms
  • Nanoparticle delivery systems
  • Vaccine manufacturing scale-up and process optimization
  • Show More (2)

Key Technologies

  • mRNA vaccine platforms
  • Nanoparticle delivery systems for vaccines
  • Cold-chain compatible vaccine formulation
  • Rapid antigen/variant update workflows
  • Show More (1)

News & Updates

Article/interview on next-generation livestock vaccines featuring company leadership.

Podcast episode discussing next-generation livestock vaccines with company representation.

Innovation profile describing the company's application of modern technologies to vaccine development.

Announcement covering company fundraising to support development of novel vaccine platform.

Company founder named Innovator of the Year by the Farm Foundation.

Founder named Iowa Biotech Leader of the Year.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.